1.	LAL-BR/2001: Study Treatment to Low Risk ALL Phase: Phase IV Type: Treatment Status: Active Age: 15 and under Sponsor: Other Protocol IDs: LAL-BR/2001, NCT00526175
2.	LAL-AR-N-2005:Study Treatment for Children High Risk Acute Lymphoblastic Leukemia Phase: Phase IV Type: Treatment Status: Active Age: 16 and under Sponsor: Other Protocol IDs: LAL-AR-N-2005, NCT00526409
3.	Treatment of High Risk Adult Acute Lymphoblastic Leukemia Phase: Phase IV Type: Treatment Status: Active Age: 16 and over Sponsor: Other Protocol IDs: LAL-AR/2003, NCT00853008
4.	Chemotherapy and Imatinib in Young Adults With Acute Lymphoblastic Leukemia Ph (BCR-ABL) POSITIVE Phase: Phase IV Type: Treatment Status: Active Age: 55 and under Sponsor: Other Protocol IDs: LAL Ph-2008, NCT01491763
5.	Treatment of Acute Lymphoblastic Leukemia HIGH RISK BCR / ABL NEGATIVE IN ADULTS Phase: Phase IV Type: Treatment Status: Active Age: 15 to 60 Sponsor: Other Protocol IDs: LAL-AR/2011, NCT01540812
6.	Combination Chemotherapy With or Without Rituximab in Treating Younger Patients With Stage III-IV Non-Hodgkin Lymphoma or B-Cell Acute Leukemia Phase: Phase III, Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and under Sponsor: NCI, Other Protocol IDs: CDR0000732604, COG-ANHL1131, ANHL1131, NCT01595048
7.	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia Phase: Phase III Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 1 to 30 Sponsor: NCI, Other Protocol IDs: CDR0000706370, COG-AALL1131, AALL1131, NCT01406756
8.	Phase II Study of a High-Risk Pediatric Treatment Regimen in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia. Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information. Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Approved-not yet active Age: 18 to 50 Sponsor: NCI Protocol IDs: OSU-08066, OSU 08066, 2008C0112, DFCI-06254, NCT01005758
9.	Use of Low Dose Ketoconazole in Prostate Cancer That Does Not Respond to Hormone Therapy and Prior Chemotherapy Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 200916901, UCDCC#218, NCT00895310
10.	Randomized Study of Two Combination Chemotherapy Regimens in Children With Newly Diagnosed Acute Lymphoblastic Leukemia. Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information. Phase: No phase specified Type: Treatment Status: Active Age: Child Sponsor: Other Protocol IDs: POWH-CRE-2008.077-T, CRE-2008.077-T, NCT00707083